SCHEMBL537673

SCHEMBL537673

CSc1nc(O)cc(O)n1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.42
KMT2A Q03164 6/20 0.38
MEN1 O00255 4/20 0.38
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
THRB P10828 1/20 0.37
PKM P14618 1/20 0.36
POLB P06746 2/20 0.36
HSP90AB1 P08238 2/20 0.36
APP P05067 1/20 0.35
KDM4E B2RXH2 2/20 0.34
MAPT P10636 2/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HTT P42858 3/20 0.33
RXFP1 Q9HBX9 1/20 0.33
HSP90AA1 P07900 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10389241 0.97 MAPK1 (0.41) MAPK1KMT2AMEN1GAASMN1; SMN2
SCHEMBL29352953 0.97 MAPK1 (0.41) MAPK1KMT2AMEN1GAASMN1; SMN2
SCHEMBL10389212 0.97 MAPK1 (0.41) MAPK1KMT2AMEN1GAASMN1; SMN2
SCHEMBL28715240 0.97 MAPK1 (0.41) MAPK1KMT2AMEN1GAASMN1; SMN2
SCHEMBL1598214 0.85 KMT2A (0.49) MAPK1KMT2AMEN1GAATHRB
SCHEMBL3110403 0.84 KMT2A (0.51) MAPK1KMT2AMEN1GAASMN1; SMN2
SCHEMBL30591631 0.84 HSP90AB1 (0.39) MAPK1KMT2AMEN1GAASMN1; SMN2
SCHEMBL163966 0.84 HSP90AB1 (0.39) MAPK1KMT2AMEN1GAASMN1; SMN2
SCHEMBL8182271 0.80 KMT2A (0.45) KMT2AMEN1GAATHRBKDM4E
SCHEMBL5749312 0.80 NOS3 (0.34) MAPK1KMT2AMEN1GAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 573 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114933568-B Preparation method of 4, 6-dimethyl-2-methylsulfonyl pyrimidine 抚州润泰药业有限公司 2024-11-26 CN claimed
CN-118307483-A Preparation method of 2-methylsulfonyl-4, 6-dimethoxy pyrimidine 新沂大江化工有限公司 2024-07-09 CN claimed
US-20240154124-A1 NEGATIVE ELECTRODE PLATE AND LITHIUM-ION BATTERY COMPRISING SAME ZHUHAI COSMX BATTERY CO., LTD. (CN) 2024-05-09 US claimed
CN-220257206-U 4-6-dihydroxy-2-methylthiopyrimidine hydrothermal recrystallization kettle 江苏鸣翔化工有限公司 2023-12-29 CN claimed
CN-114933568-A Preparation method of 4, 6-dimethyl-2-methylsulfonyl pyrimidine 抚州润泰药业有限公司 2022-08-23 CN claimed
CN-110372605-B Synthesis method of 2-methylthio-4, 6-dichloro-5-nitropyrimidine 南京普锐达医药科技有限公司 2022-05-13 CN claimed
CN-112552244-A Production process of 4, 6-dimethoxy-2-methylsulfonyl pyrimidine 内蒙古科硕新材料科技有限公司 2021-03-26 CN claimed
CN-110372605-A Synthesis method of 2-methylthio-4, 6-dichloro-5-nitropyrimidine 南京普锐达医药科技有限公司 2019-10-25 CN claimed
CN-109851565-A A kind of preparation method of the chloro- 2- methylthiopyrimidine of 4,6- bis- 苏州华诺医药有限公司 2019-06-07 CN claimed
CN-105026376-B Process for the preparation of bispyribac-sodium and intermediates thereof 加尔达化学有限公司 2018-05-11 CN claimed
WO-2014128719-A2 PROCESSES FOR THE PREPARATION OF BISPYRIBAC SODIUM AND INTERMEDIATES THEREOF GHARDA CHEMICALS LTD (IN) 2014-08-28 WO claimed
US-7384533-B2 Electrolytic processes with reduced cell voltage and gas formation 3M INNOVATIVE PROPERTIES COMPANY (US) 2008-06-10 US claimed
CN-1396158-A Process for synthesizing 4,6-dimethoxy-2-methiopyrimidine UNIV ZHEJIANG POLYTECHNIC (CN) 2003-02-12 CN claimed
CN-1343665-A Process for preparing 4,6-dichloro-2-methiopyrimidine SHAXING CHEMICAL CO LTD TAIZHO (CN) 2002-04-10 CN claimed
US-20250313554-A1 PTPN2 INHIBITORS MONDEGO BIO, LDA. (PT) 2025-10-09 US disclosed
EP-4522594-A1 PTPN2 INHIBITORS Ness Therapeutics, Inc. (US) 2025-03-19 EP disclosed
CN-114933568-B Preparation method of 4, 6-dimethyl-2-methylsulfonyl pyrimidine 抚州润泰药业有限公司 2024-11-26 CN disclosed
US-4059696-A INSECTICIDE, MITICIDE BAYER AKTIENGESELLSCHAFT (DT) 1977-11-22 US disclosed
US-4045561-A Pesticidal pyrimidinyl phosphorus esters SANDOZ LTD. (CH) 1977-08-30 US disclosed
US-3931180-A Substituted 6-hydroxy pyrimidines SANDOZ LTD., (SANDOZ AG) (CH) 1976-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250313554-A1 PTPN2 INHIBITORS PTPN2, PTPN1, PTPRJ MAPK1 190/4885KMT2A 1912/4885MEN1 3303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.